Holen Sie sich die Stockscreener-App
13.99
2.71%
-0.39
Handel nachbörslich:
13.72
-0.27
-1.93%
Finanzdaten der Amylyx Pharmaceuticals Inc-Aktie (AMLX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | -0.665 |
| Cost Of Revenue |
-
|
- | - | - | - |
Selling, General, and Administrative
|
4.82%
15.39
|
16.17 | 15.64 | 15.68 | - |
| Costs And Expenses |
1.60%
36.60
|
36.03 | 42.86 | 37.80 | 39.99 |
| Operating Income/Loss |
1.60%
-36.60
|
-36.03 | -42.86 | -37.80 | -40.65 |
| Nonoperating Income/Loss |
122.55%
3.652
|
1.641 | 1.414 | 1.896 | 2.473 |
| Income/Loss From Continuing Operations Before Tax |
4.17%
-32.95
|
-34.39 | -41.44 | -35.91 | -38.18 |
| Income Tax Expense/Benefit |
0.046
|
- | - | - | -0.635 |
| Income/Loss From Continuing Operations After Tax |
4.03%
-33.00
|
-34.39 | -41.44 | -35.91 | -37.55 |
|
Net Income/Loss
|
4.03%
-33.00
|
-34.39 | -41.44 | -35.91 | -37.55 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.48%
5.1481
|
93.33 | 89.14 | 85.70 | 0.1515 |
| Diluted Average Shares |
94.48%
5.1481
|
93.33 | 89.14 | 85.70 | 0.1515 |
| Basic Earnings Per Share |
24.32%
-0.28
|
-0.37 | -0.46 | -0.42 | -0.54 |
| Diluted Earnings Per Share |
24.32%
-0.28
|
-0.37 | -0.46 | -0.42 | -0.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.15%
3.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):